MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRANKLIN, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRANKLIN, M. R.

Molecular Pharmacology, Vol 8, 722-730, Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics

The Conversion of Hepatic Cytochrome P-450 to P-420 in Normal and Phenobarbital- and 3-Methylcholanthrene-Treated Animals

MICHAEL R. FRANKLIN 1

1 Department of Biochemistry, The University of Texas Southwestern Medical School at Dallas, Dallas Texas 75235

The conversion of rat and rabbit hepatic microsomal cytochrome P-450 to P-420 by mercurials does not proceed to completion. The percentage of cytochrome P-450 resistant to mercurial attack was greater in rats than in rabbits. It was increased by prior treatment with phenobarbital and decreased when the animals had been treated with 3-methylcholanthrene. Correlative studies using ethyl isocyanide as a ligand for reduced cytochrome P-450 instead of carbon monoxide demonstrated a loss of the 455 nm absorbance maximum in this difference spectrum, closely paralleling the loss of cytochrome P-450. The loss of the 455 nm absorbance maximum, however, did not always result in an increase in the absorbance maximum at 430 nm. The effect of low concentrations of mersalyl on the electron paramagnetic resonance spectrum at -172° of microsomes from 3-methylcholanthrene-treated animals suggests the presence of an undetectable form of cytochrome P-450. The differences in the susceptibility of cytochrome P-450 from different sources to mercurial degradation probably reflect changes in the whole population of cytochrome P-450 present in the microsomes.

Note:
ACKNOWLEDGMENTS The author thanks Mrs. Nancy J. Mahanay for her technical assistance, and Dr. Ronald W. Estabrook for his interest, encouragement, and advice.

Submitted on April 4, 1972







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1972 by the American Society for Pharmacology and Experimental Therapeutics